Antibody targeted drugs as cancer therapeutics
- PMID: 16424916
- DOI: 10.1038/nrd1957
Antibody targeted drugs as cancer therapeutics
Abstract
Treatment of cancer is a double-edged sword: it should be as aggressive as possible to completely destroy the tumour, but it is precisely this aggressiveness which often causes severe side effects - a reason why some promising therapeutics can not be applied systemically. In addition, therapeutics such as cytokines that physiologically function in a para- or autocrine fashion require a locally enhanced level to exert their effect appropriately. An elegant way to accumulate therapeutic agents at the tumour site is their conjugation/fusion to tumour-specific antibodies. Here, we discuss recent preclinical and clinical data for antibody-drug conjugates and fusion proteins with a special focus on drug components that exert their antitumour effects through normal biological processes.
Similar articles
-
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case.Immunobiology. 2009;214(9-10):800-10. doi: 10.1016/j.imbio.2009.06.005. Epub 2009 Jul 21. Immunobiology. 2009. PMID: 19625102 Review.
-
Targeted cancer therapy: conferring specificity to cytotoxic drugs.Acc Chem Res. 2008 Jan;41(1):98-107. doi: 10.1021/ar700108g. Epub 2007 Aug 18. Acc Chem Res. 2008. PMID: 17705444 Review.
-
Human toxin-based recombinant immunotoxins/chimeric proteins as a drug delivery system for targeted treatment of human diseases.Expert Opin Drug Deliv. 2011 May;8(5):605-21. doi: 10.1517/17425247.2011.566269. Epub 2011 Apr 1. Expert Opin Drug Deliv. 2011. PMID: 21453191 Review.
-
Antibody drug conjugates - Trojan horses in the war on cancer.J Pharmacol Toxicol Methods. 2011 Nov-Dec;64(3):207-12. doi: 10.1016/j.vascn.2011.07.005. Epub 2011 Aug 6. J Pharmacol Toxicol Methods. 2011. PMID: 21843648 Review.
-
Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.Handb Exp Pharmacol. 2008;(181):291-328. doi: 10.1007/978-3-540-73259-4_13. Handb Exp Pharmacol. 2008. PMID: 18071951 Review.
Cited by
-
The antibody-mediated targeted delivery of interleukin-13 to syngeneic murine tumors mediates a potent anticancer activity.Cancer Immunol Immunother. 2015 May;64(5):635-44. doi: 10.1007/s00262-015-1666-8. Epub 2015 Feb 27. Cancer Immunol Immunother. 2015. PMID: 25722088 Free PMC article.
-
Versatile Peptide-Based Nanosystems for Photodynamic Therapy.Pharmaceutics. 2024 Feb 2;16(2):218. doi: 10.3390/pharmaceutics16020218. Pharmaceutics. 2024. PMID: 38399272 Free PMC article. Review.
-
Design, synthesis, and biological evaluation of pyrazole-linked aloe emodin derivatives as potential anticancer agents.RSC Med Chem. 2021 Apr 26;12(5):791-796. doi: 10.1039/d0md00315h. eCollection 2021 May 26. RSC Med Chem. 2021. PMID: 34124677 Free PMC article.
-
Large granular lymphocyte leukemia: from dysregulated pathways to therapeutic targets.Future Oncol. 2012 Jul;8(7):787-801. doi: 10.2217/fon.12.75. Future Oncol. 2012. PMID: 22830400 Free PMC article. Review.
-
Alterations in Cellular Processes Involving Vesicular Trafficking and Implications in Drug Delivery.Biomimetics (Basel). 2018 Jul 24;3(3):19. doi: 10.3390/biomimetics3030019. Biomimetics (Basel). 2018. PMID: 31105241 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
